Mastitis is pathological inflammation of the mammary tissue mostly caused by infectious agents. It is considered the most common disease leading to severe financial losses due to disposal of infected milk, veterinarian costs, treatment and hygiene expenses, as well as early culling of affected animals from the herd. The total financial loss due to a dairy cattle suffering from mastitis is between €65 and €182 per cow/per year (Huijps et al., Reference Huijps, Lam JGM and Hogeveen2008). Clinical and subclinical mastitis are fundamental entitles in dairy cattle and clinical mastitis is characterized by sudden onset, alterations of milk quality and appearance, decreased milk production, and the presence of the basic signs of inflammation. The diagnosis of acute mastitis is fairly easy and rapid, and treatment interventions are largely successful. On the contrary, subclinical mastitis is insidious and there are no visible signs of inflammation except a decrease in milk production (Sharun et al., Reference Sharun, Dhama, Tiwari, Gugjoo, Yatoo, Patel, Pathak, Karthik, Khurana, Singh, Puvvala, Amarpal, Singh, Singh and Chaicumpai2021). Inefficient treatment protocols as well as the prolonged inflammatory process in subclinical mastitis causes loss of functional units and progressive fibrosis in the mammary tissue. Fibrosis can be briefly defined as an increase in extracellular matrix (ECM) components and the proliferation of connective tissue cells. It occurs irreversibly following chronic inflammation in various tissues (Dees et al., Reference Dees, Chakraborty and Distler2020). The replacement of the parenchyma with fibrotic tissue leads to dysfunction, which in the mammary tissue is characterized by a severe decrease or cessation of milk production. It is not possible to completely prevent or reverse fibrosis within the current medical capabilities. New and effective therapeutic approaches can only be possible with the understanding of the pathogenesis of fibrosis. One of the novel candidates in the combat against fibrosis may be MCs and their unique cytoplasmic proteases such as tryptase and chymase (Asano-Kato et al., Reference Asano-Kato, Fukagawa, Okada, Dogru, Tsubota and Fujishima2005; Kosanovic et al., Reference Kosanovic, Luitel, Dahal, Cornitescu, Janssen, Danser, Garrelds, De Mey, Fazzi, Schiffers, Iglarz, Fischli, Ghofrani, Weissmann, Grimminger, Seeger, Reiss and Schermuly2015). MCs originate from pluripotent hematopoietic progenitor cells of the bone marrow (Elieh Ali Komi et al., Reference Elieh Ali Komi, Wöhrl and Bielory2020). Immature precursor MCs remain in circulation for a short period and then travel to tissues where they acquire the morphological and biochemical characteristics of mature MCs under the influence of growth factors such as stem cell factor, interleukin-3 (IL-3), IL-4, IL-10, IL-33, stromal cell-derived factor-1, nerve growth factor and transforming growth factor-β (TGF-β) (Elieh Ali Komi et al., Reference Elieh Ali Komi, Wöhrl and Bielory2020). MCs are divided into 3 different immunophenotypes as tryptase + mast cells (MCT), chymase (+) mast cells (MCC), and tryptase-chymase + mast cells (MCTC) according to their cytoplasmic enzyme contents (Moon et al., Reference Moon, Befus and Kulka2014). Although the presence of MCs in developing and adult mammary tissues of heifers and cows has been examined histochemically and by electron microscopy, no data on the immunophenotypes of MCs were found (Nielsen, Reference Nielsen1975; Beaudry et al., Reference Beaudry, Parsons, Ellis and Akers2016). MCs were only nominally mentioned among other inflammatory cells in studies on the histopathological features of bovine mastitis (Nickerson and Heald, Reference Nickerson and Heald1982), but no detailed information was provided. MCs have the function of killing non-phagocytosed bacterial clusters in the extracellular space through the production of extracellular traps containing DNA fragments, histone proteins, tryptase enzymes and antibacterial peptides (Möllerherm et al., Reference Möllerherm, von Köckritz-Blickwede and Branitzki-Heinemann2016). Therefore, MCs may be important in mastitis, which is mostly caused by bacteria. Though MCs have cardinal function in innate and acquired immune responses, their effect on fibrosis has been questioned in recent years (Summers et al., Reference Summers, Gan, Dewage, Ma, Ooi, O'Sullivan, Nikolic-Paterson, Kitching and Holdsworth2012; Lombardo et al., Reference Lombardo, Broadwater, Collins, Cebe, Brady and Harrison2019). There are studies examining the possible role of MCs and their mediators in experimentally induced fibrosis in various organs such as the lung, kidney, liver and heart (Matsumoto et al., Reference Matsumoto, Wada, Tsutamoto, Ohnishi, Isono and Kinoshita2003; Komeda et al., Reference Komeda, Takai, Jin, Tashiro, Hayashi, Tanigawa and Miyazaki2010; Summers et al., Reference Summers, Gan, Dewage, Ma, Ooi, O'Sullivan, Nikolic-Paterson, Kitching and Holdsworth2012; Overed-Sayer et al., Reference Overed-Sayer, Miranda, Dunmore, Liarte Marin, Beloki, Rassl and Clarke2020) and it has been reported that the severity of fibrosis is significantly reduced in tissues where MCs are inhibited. Furthermore, results of studies in mast cell-deficient mouse models revealed that these animals are protected from renal and pulmonary fibrosis, whilst reintroduction of wild-type bone marrow-derived mast cells into mast cell-deficient mice restored fibrosis (Summers et al., Reference Summers, Gan, Dewage, Ma, Ooi, O'Sullivan, Nikolic-Paterson, Kitching and Holdsworth2012; Veerappan et al., Reference Veerappan, O'Connor, Brazin, Reid, Jung, McGee, Summers, Branch-Elliman, Stiles, Worgall, Kaner and Silver2013).
The effects of MC tryptase and chymase enzymes on the fibrotic process have been examined. Tryptase enzyme has been shown to increase fibroblast proliferation, migration and collagen synthesis. Increased MCT with elevated pulmonary tryptase levels has been reported in pulmonary fibrosis (Wygrecka et al., Reference Wygrecka, Dahal, Kosanovic, Petersen, Taborski, von Gerlach, Didiasova, Zakrzewicz, Preissner, Schermuly and Markart2013). Similarly, a significantly increased number of MCC phenotype MCs were reported in hypertrophic cutaneous lesions by Chen et al. (Reference Chen, Xu, Yang, Zhang, Huang, Yu and Dong2017). They also demonstrated that chymase augments dermal fibroblast proliferation and collagen synthesis in vitro. Similarly, chymase treatment also induces proliferation and collagen synthesis in cardiac fibroblasts (Zhao et al., Reference Zhao, Zhao, Zheng, Su, Guan, Shang, Niu, He and Lu2008). Matsumoto et al. (Reference Matsumoto, Wada, Tsutamoto, Ohnishi, Isono and Kinoshita2003) reported that the number of MCs in cardiac tissue was increased in dogs with fibrosis and emphasized that chymase inhibition both prevents fibrosis and improves diastolic dysfunction. Kanemitsu et al. (Reference Kanemitsu, Takai, Tsuneyoshi, Yoshikawa, Nishina, Miyazaki, Ikeda and Komeda2008) demonstrated that chronic inhibition of chymase prevented fibrosis after the myocardial infarction model. Although the role of MCs in naturally occurring or experimentally induced fibrosis in various animals has been studied, there are no data on bovine mammary tissue. Therefore, we aimed to investigate the presence of MCs and identify their immune phenotypes in healthy and mastitic mammary tissues with fibrosis. We believe that it is essential to examine whether mammary fibrosis is associated with an increased number of MCs for further clinical studies aimed at treatment or alleviation of fibrotic changes.
Material and methods
A total of 264 bovine mammary samples were collected from a local slaughterhouse (Bursa, Turkey). The presence of mastitis in the samples, the number of healthy, acute-chronic mastitic tissues and the parameters used in this classification are presented in the first part of the results section. The study was approved by the University of Bursa Uludağ Institutional Animal Care and Use Committee (Protocol Number: 2019-07/04). Sampling, tissue processing and staining for microscopical evaluation are detailed in the Supplementary file.
Masson's trichrome staining procedure was used to demonstrate connective tissue and fibrosis in mammary tissues. The amount of connective tissue was analysed in digital images taken from 10 randomly selected fields at ×200 magnification in a microscope using Olympus Stream Motion software (Shinjuku, Tokyo, Japan). The image analysis protocol is detailed in Supplementary Figs S1–S3.
MCs in mammary samples were demonstrated by toluidine blue staining. The number, localization and activity (granulated/degranulated) of MCs in 10 randomly selected fields were evaluated in a blinded manner. MCs were considered as degranulated if there was an extensive dispersion of more than 15 extruded vesicles localized near the cell, or an extensive loss of granule staining, giving the cell a ‘ghostly’ look. The number of granulated, degranulated and total MCs were expressed as mean numbers and fold increases for each group.
The immunohistochemical staining was performed using UltraVision Detection System anti-polyvalent HRP/DAB (TP-015-HD, Thermo Fisher Scientific, Waltham, MA, USA) to detect the localization of MCT, MCC and MCTC. Isotope IgG antibody was applied to achieve negative control staining and skin samples were used as the positive control. Detailed immunohistochemistry protocol is given in the Supplementary File.
Statistical data analysis was performed using IBM SPSS Statistics version 20. Data was tested with the Shapiro–Wilk test for normal distribution. Group comparisons were performed using the one-way analysis of variance (ANOVA) test when data were normally distributed, otherwise, the Kruskal–Wallis test was used. Results were considered significant at P < 0.05. In addition, the Pearson correlation test was used to determine the correlation between mast cells and fibrotic lesions in chronic mastitis samples.
Results
Healthy and functionally active mammary glands had a soft consistency; cross-sectional surfaces of healthy samples displayed pinkish-cream colour and a well-developed lobuloalveolar structure. Milk oozing was evident from the cut surfaces of these samples. Supramammary lymph nodes of normal size and consistency were observed. In cases of acute mastitis, redness, presence of oedema, purulent exudation and clotted milk were noted in the cut surfaces of mammary samples. In addition to these common findings, necrotic changes with discolorations were detected in some cases. Firm mammary lobules with thick, white interlobular fibrous tissues were primary findings in chronic mastitis cases (online Supplementary File Fig. S4). No milk production was observed in those samples.
Histopathologically, no prominent lesions were observed in 119 out of 264 mammary samples (45.7%: online Supplementary Figs S5A, B). Hyperaemic blood vessels, oedema in interlobular spaces, neutrophil leucocyte infiltrations of varying severity in alveolar and duct lumens, degenerated and necrotic alveolar and tubular epithelial cells were noticed in acutely inflamed samples (101/264, 38%: online Supplementary Figs S6A, B). Chronic mastitis was diagnosed in 44 out of 264 (16.6%) of mammary samples. Microscopic examination of mammary samples with chronic mastitis revealed fibrous tissue proliferation together with mononuclear cell infiltrations in the interstitial spaces and severe atrophy in alveolar structures (online Supplementary Figs S7A, B).
MCs with metachromatic granules were visualized by toluidine blue staining in tissue sections and they were localized around blood and lymph vessels, interstitial spaces, alveoli and ducts in healthy mammary tissues (online Supplementary Figs S8A, B). In normal bovine mammary tissue, a small number of MCs were found, in particular around vessels of connective tissue. MC numbers were significantly increased in tissue samples with acute and chronic mastitis when compared with healthy controls. In contrast to healthy samples, the localization of mast cells was shifted in mastitic tissues, in that a large number of mast cells were observed not only in the interstitial area but also in the parenchymal tissue. The mean number of MCs in healthy tissues was found to be 4.14. The mean number of MCs in acute mastitis cases was significantly increased (10.05) and there was a 2.42-fold increase in the number of MCs compared to healthy mammary tissues (P < 0.001). The mean number of MCs in tissue samples with chronic mastitis was found to be 32.7 and a 7.9-fold increase was detected when compared with healthy controls (P < 0.001). Furthermore, the activity of MCs was evaluated according to whether they were degranulated or not. The mean number of degranulated MCs in healthy controls, acute mastitis and chronic mastitis cases were 1, 2.5, and 6.8, respectively. Therefore, the mean number of degranulated MCs was 2.5-fold higher in acute mastitis cases and 6.8-fold higher in chronic mastitis cases compared to healthy controls. The mean number of intact and degranulated MCs and fold increases in healthy, acute and chronic mastitis mammary tissues are summarized in online Supplementary Table S1 and the P values are summarized in online Supplementary Table S2.
Immunohistochemical staining results revealed that all three phenotypes of MCs (MCT, MCC, and MCTC) were detected in healthy controls and mastitic samples (Figs. 1–3). The mean number of MCT in healthy controls, acute and chronic mastitis cases were 1.8, 4.4, and 19, respectively. No statistically significant difference was found when MCT in healthy controls was compared with acute mastitis cases (P > 0.05). A statistically significant difference was found when MCT in healthy controls was compared with samples with chronic mastitis (P < 0.001). Similarly, when MCT cells in acute and chronic mastitis were compared with each other, the difference was found to be statistically significant (P < 0.001).
Figure 1. Tryptase positive mast cells (arrows and double-headed arrows) around the alveoli in (a) healthy mammary tissue, (b) mammary tissue with acute mastitis showing increased number as well as presence in neutrophil infiltrations within the lumen of alveoli and (c) in the interstitial areas of mammary tissue with chronic fibrotic mastitis, showing greatly increased number. Streptavidin–biotin–peroxidase method, DAB chromogen, ×200 magnification.
Figure 2. Chymase-positive mast cells (arrows) around the alveoli in (a) healthy mammary tissue, (b) mammary tissue with acute mastitis showing increased number as well as presence in neutrophil infiltrations within the lumen of alveoli and (c) in the interstitial areas of mammary tissue with chronic fibrotic mastitis, showing greatly increased number. Streptavidin–biotin–peroxidase method, DAB chromogen, ×200 magnification.
Figure 3. Determination of tryptase–chymase positive mast cell phenotype in serial sections of mammary tissues. Determination of tryptase–chymase + mast cell phenotype according to tryptase (top picture) and chymase (bottom picture) staining results. Mast cells in rectangles are those stained positively with both tryptase and chymase antibodies and have tryptase-chymase + mast cell phenotype. Cells marked with triangles and circles are mast cells with tryptase + and chymase + phenotypes, respectively. Streptavidin-biotin peroxidase, DAB, ×200 magnification.
The mean number of MCC in healthy controls, acute and chronic mastitis cases were 1, 2.6, and 7.8, respectively. When the mean number of MCC observed in healthy controls was compared with the mean number of MCC in samples with acute and chronic mastitis, the increases observed in both acute and chronic mastitis were statistically significant (both P < 0.001). Finally, the mean numbers of MCTC phenotypes were compared in healthy, acute, and chronic mastitis groups. No statistically significant difference was found between healthy control and acute mastitis samples (P > 0.05), but a statistically significant difference was found between healthy and chronic mastitis groups (P < 0.01). When the mean MCTC number of acute mastitis and chronic mastitis samples were compared with each other, the difference was statistically significant (P > 0.01). The mean number of MC phenotypes and fold increases in healthy, acute and chronic mastitic samples are summarized in the Supplementary file (Online Supplementary Table S3 and P values in Table S4).
Fibrotic changes in mammary samples were evaluated by Masson's trichrome staining and measured by ImageJ analysis software. The average amounts of connective tissue measured in controls and samples with acute mastitis were found to be 9.9 and 12.35%, respectively, and no statistical significance was found. The average amount of connective tissue in chronic mastitic samples reached 29.83%. Compared to the control group, the average amount of connective tissue increased 3.01-fold in chronic mastitic samples. The possible relationship between MCs and fibrosis in samples with chronic mastitis was also investigated by correlation analyses and it was found that there was a positive correlation between the increasing number of total MCs and the severity of fibrosis (Pearson's correlation coefficient (r) for total MCs: 0.76; P < 0.05). A similar positive correlation was also obtained from the total number of granulated and degranulated mast cells with tissue fibrosis (Pearson's correlation coefficient (r) for granulated MCs 0.69 and for degranulated MCs 0.55, both P < 0.05).
Discussion
We have investigated the presence and immune phenotypes of MCs in normal bovine mammary tissue, and results were compared with acute and chronic mastitic samples displaying non-fibrotic and fibrotic changes, respectively. To the best of our knowledge, this is the first detailed documentation of the existence of MCs in bovine mammary tissue and mastitis. In the following sections, since there is no data on the presence and immune phenotypes of MCs in bovine mammary tissues, the results are mainly discussed in relation to results of previous human and laboratory animal studies.
The majority of mastitis cases in dairy cattle are subclinical and the inflammation in the mammary tissue progresses insidiously, fibrosis is inevitable in cases that are not diagnosed in the early stages of inflammation or not completely treated. MCs are innate immune cells and have pivotal roles in the modulation of acute and chronic inflammation. These heterogeneous cells are classified according to their histochemical staining features and in their content of preformed biological granules. This heterogeneity directly affects their functions and responses to inflammatory stimuli. Moreover, this heterogeneity is remarkable even in different micro-anatomical localization of organs (Bradding, Reference Bradding2009). For example, different lung compartments in humans contain mast cells with distinct granules, which can be classified as MCs containing either tryptase only (MCT), chymase only (MCC), or both tryptase and chymase (MCTC). Weidner and Austen (Reference Weidner and Austen1993), reported that MCTC and MCT phenotypes were present in human breast tissue, but the MCC phenotype was not found. The results of our study showed that MCs with three distinct phenotypes are present in bovine mammary tissue, which is different from human. In bovine mammary tissue, MCs are localized around stromal blood and lymph vessels, in the interalveolar interstitial tissue and around the duct system. Microanatomically, it was noted that MC immune phenotypes did not exhibit a specific distribution pattern and all phenotypes were present in the indicated histologic compartments.
The presence of a large number of MCs in tissues in close contact with the external environment increases the importance of the evaluation of these cells in mammary tissue. In this study, the parenchyma of the mammary tissue was the primarily examined compartment. Although we have histochemically examined MC distribution in mammary papillae (results were not included), immunohistochemical examinations have not been performed. Studies on the localization of MCs even in healthy mammary tissue are extremely limited and there is no data on their presence, immune phenotypes and possible roles in mastitis. In the study by Beaudry et al. (Reference Beaudry, Parsons, Ellis and Akers2016), the localization and numbers of MCs in bovine prepubertal mammary tissue were investigated. Although their study provides valuable data on the roles of MCs in the development of mammary tissue, no data on the phenotype of these cells were provided. Additionally, one of the most important differences between the studies is our examination of histochemical and immune phenotypes of MCs in both healthy and mastitic tissues. The presence of MCs in pregnant, lactating and involuting mouse mammary glands has also been documented (Szewczyk et al., Reference Szewczyk, Szukiewicz, Zaczek and Maslinska2000; Lilla et al., Reference Lilla, Joshi, Craik and Werb2009). In the study by Lilla et al. (Reference Lilla, Joshi, Craik and Werb2009) only the chymase positive phenotype of MCs was targeted and the presence of this phenotype in healthy mammary tissue of mice was demonstrated, but no data on other phenotypes were included. Szewczyk et al. (Reference Szewczyk, Szukiewicz, Zaczek and Maslinska2000) examined the presence and number of mast cells histochemically in the development and involution of mammary tissue in mice, but they did not provide any data on mast cell immune phenotypes. Our research differs from the study of Szewczyk et al. (Reference Szewczyk, Szukiewicz, Zaczek and Maslinska2000) since it provides data on mast cells and their immune phenotypes in mammary samples, as well as including healthy and mastitic tissues.
Fibrosis can be defined as the gradual loss of parenchymal units and an increase in connective tissue cells and non-functional extracellular matrix proteins. This process is irreversible and there is no effective treatment. MCs can synthesize a wide range of mediators with profibrotic properties such as TGF-β, platelet-derived growth factor and fibroblast growth factor (Dees et al., Reference Dees, Chakraborty and Distler2020). These mediators stimulate fibroblasts to produce ECM components. In addition, MC tryptase promotes collagen synthesis by fibroblasts. The upregulated proliferation of conjunctival fibroblasts by tryptase treatment in a dose-dependent manner has been demonstrated (Asano-Kato et al., Reference Asano-Kato, Fukagawa, Okada, Dogru, Tsubota and Fujishima2005) and the authors also reported that inhibition of tryptase activity via specific receptor blockers prevented tyrptase-induced fibroblast proliferation. Frungieri et al. (Reference Frungieri, Albrecht, Raemsch and Mayerhofer2005) have demonstrated that MCs actively contribute to liver fibrosis via the release of tryptas, and Lombardo et al. (Reference Lombardo, Broadwater, Collins, Cebe, Brady and Harrison2019) reported a direct correlation between the number of mast cells and severity of hepatic fibrosis. The results of previous experimental studies have revealed that tryptase phenotype MCs are more prominent than the other two MC phenotypes in the formation of fibrosis in different organs. In our study, an increased number of MCs with tryptase phenotype were found in fibrotic mammary tissue, which is consistent with previous studies. Chymase is another important component of MCs involved in fibrosis in various organs (Matsumoto et al., Reference Matsumoto, Wada, Tsutamoto, Ohnishi, Isono and Kinoshita2003; Komeda et al., Reference Komeda, Takai, Jin, Tashiro, Hayashi, Tanigawa and Miyazaki2010; Pons et al., Reference Pons, Ali, Beghdadi, Danelli, Alison, Madjène, Calvo, Claver, Vibhushan, Åbrink, Pejler, Poli-Mérol, Peuchmaur, El Ghoneimi and Blank2017). Pons et al. (Reference Pons, Ali, Beghdadi, Danelli, Alison, Madjène, Calvo, Claver, Vibhushan, Åbrink, Pejler, Poli-Mérol, Peuchmaur, El Ghoneimi and Blank2017) showed that MC chymase contributes to renal fibrosis through the epithelial-mesenchymal transition in the ureteral obstruction model. Matsumoto et al. (Reference Matsumoto, Wada, Tsutamoto, Ohnishi, Isono and Kinoshita2003) demonstrated that chymase inhibition is important in the prevention of cardiac fibrosis in dogs. Similarly, Komeda et al. (Reference Komeda, Takai, Jin, Tashiro, Hayashi, Tanigawa and Miyazaki2010) reported that chymase inhibition resulted in the attenuation of liver fibrosis in hamsters. Our results provide scientific background for further clinical approaches targeting fibrosis in bovine mammary gland.
Since the degranulation of MCs is a useful indicator of their activity, we also evaluated the number of degranulated MCs in the tissue sections and showed that it was greatly increased in acute and chronic mastitis. This indicates that the increased number and activity of MCs in tissues with mastitis (acute and/or chronic) may play important roles in the pathogenesis of bovine mastitis.
In conclusion, we found that the total number of MCs was significantly increased in mammary samples with mastitis and the mean number of MCs was highest in chronic fibrotic mastitis cases. We demonstrated statistical correlations between increased densities of MCs, degree of fibrosis and parenchymal collagen density in chronic mastitic samples. These observations shed light on the possible role of MCs in the pathogenesis of mammary fibrosis. Further studies are needed to understand the clinical significance of MC inhibition in the prevention or alleviation of fibrotic changes in bovine mastitis.
Supplementary material
The supplementary material for this article can be found at https://doi.org/10.1017/S0022029923000651
Acknowledgment
This work was supported by The Scientific and Technological Research Council of Türkiye (TUBITAK-TOVAG-Research Project ID: 118O893).
Open access
